HealthDay News — Telemedicine is supported as a method of health care delivery for allergists and immunologists, according to a position paper presented at the American College of Allergy, Asthma and Immunology Annual Scientific Meeting, being held October 26 to 30 in Boston.
Noting that telemedicine is associated with beneficial outcomes, Tania Elliott, MD, and colleagues discussed use of telemedicine for allergists.
The authors support use of telemedicine as a method of health care delivery. Telemedicine activities should account for varying levels of literacy and technologic literacy and strive for ease of use. Telemedicine must be secure and comply with state and federal regulations. Medical liability coverage should include a provision for telemedicine services. Quality assurance measures should be in place to track patient satisfaction, physician performance, and clinical outcomes. The same standards of care, professionalism, and ethics should be in place for live interactive video visits with patients as for in-person consultations. At all times, best practices for safety in telemedicine care delivery should be followed. Telemedicine use is likely to expand for allergy care, with broader applications in medicine; further research is needed into the impact and outcomes.
“The goal is to have an exceptional user experience,” one of the co-authors said in a statement. “The nature of mobile and tech development is bringing the patient back into focus and putting them first again.”